Risks and benefits associated with mail-order pharmacies and third-party platforms, according to Amanda Bogle, a healthcare ...

Without guardrails, artificial intelligence can be abused, leading to overbilling and high volumes of appeals. But with the ...

In a video interview with MHE editors, Nathan Downhour, Pharm.D., vice president of strategic pharmacy solutions at Prime Therapeutics, said a shift is already underway in the pharmacy benefit market ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.

Medicare Advantage usage trends reveal slight declines in 2023, highlighting critical insights for policymakers amid rising ...

Although a warming planet is bad for human health overall, the prognosis for schizophrenia is particularly poor, researchers argue in a commentary.

In a video interview with MHE editors, David Blair, founder, chairman, and CEO of LucyRx, expressed his belief that pharmacists are an underused resource in the U.S. healthcare system, especially at a ...

Pharmacies and PBMs face growing regulatory and reporting demands around drug pricing and reimbursement, while misalignment between state rules and payer practices complicates the expanded clinical ...

The authors of an opinion piece in The Lancet Psychiatry make a case for paying more attention to the autistic features of ...

International audience surveys from last year’s menopause documentary, The (M) Factor, shed light on the ongoing need for ...

Dove’s new line of body care products was developed to address symptoms often associated with menopause, such as skin dryness and body odor.

Pavblu, an Eylea HD biosimilar, shows stable vision outcomes and minimal side effects in real-world use, promising a reliable ...